Allied Market Research

2024

Fecal Occult Testing Market

Fecal Occult Testing Market Size, Share, Competitive Landscape and Trend Analysis Report, by Product and, by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Diagnostics and Biotech

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Fecal occult test is a medical test used to check stool samples for hidden or occult blood. The presence of occult blood indicates the presence of colon cancer or polyps in the colon or rectum, ulcers, anal fissures, Crohns disease, and many more conditions. The fecal occult test is used in clinical screening to detect colon cancer.

The major factors that contribute to the growth of the fecal occult testing market include increasing prevalence of rectal & colon cancer, initiatives taken by the government such as organizing colorectal cancer check-ups, improved medical infrastructure, and adoption of advanced fecal occult testing. However, factors such as less awareness about the test and high costs may restrain the market growth. The development of direct-to-consumer laboratory testing and availability of fecal occult immunological test devices in online stores will further provide lucrative market growth opportunities during the forecast period.

The fecal occult testing market is segmented on the basis of product, end user, and region. On the basis of product, the market is segmented into guaiac FOB stool test, immuno-FOB agglutination test, lateral flow immuno-FOB test, and immuno-FOB ELISA test. According to end user, the market is divided into hospitals, clinical diagnostic laboratories, and physicians' office laboratories. Geographically, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players that operate in this market include Quidel Corporation, EIKEN CHEMICAL CO., LTD., Epigenomics AG, Beckman Coulter, Inc., Abbott Laboratories, Biohit Oyj., Polymedco CDP, LLC, Quest Diagnostics Incorporated, Randox Laboratories Ltd., and EDP Biotech.

Key Benefits

  • The study provides an in-depth analysis of the global fecal occult testing market with current trends and future estimations to elucidate imminent investment pockets.
  • The report provides information about the current and upcoming trends in the global fecal occult testing market which helps determine prevailing opportunities.
  • Comprehensive analysis of factors that drive and restrict the growth of the global fecal occult testing market has been provided.
  • Identification of factors that are instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale have been provided.
  • Key market players within the market have been profiled in this report and their strategies thoroughly analyzed, which help understand the competitive outlook of the global fecal occult testing market.

Fecal Occult Testing Market Report Highlights

Aspects Details
icon_5
By Product
  • Guaiac FOB Stool Test
  • Immuno-FOB Agglutination Test
  • Lateral Flow Immuno-FOB Test
  • Immuno-FOB ELISA Test
icon_6
By End User
  • Hospitals
  • Clinical Diagnostic Laboratories
  • Physicians' Office Laboratories
icon_7
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
icon_8
Key Market Players

Beckman Coulter Inc., Polymedco CDP LLC, Quest Diagnostics Incorporated, Biohit Oyj., Abbott Laboratories, EIKEN CHEMICAL CO.LTD., Epigenomics AG, Randox Laboratories Ltd., Quidel Corporation, EDP Biotech

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Fecal Occult Testing Market

Global Opportunity Analysis and Industry Forecast, 2023-2032